Comparative Pharmacology
Head-to-head clinical analysis: STILBESTROL versus SYNTHETIC CONJUGATED ESTROGENS A.
Peer-Reviewed Evidence
Head-to-head clinical analysis: STILBESTROL versus SYNTHETIC CONJUGATED ESTROGENS A.
STILBESTROL vs SYNTHETIC CONJUGATED ESTROGENS A
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Synthetic nonsteroidal estrogen that acts by binding to estrogen receptors (ERα and ERβ), leading to translocation to the nucleus, modulation of gene transcription, and promotion of estrogenic effects in target tissues.
Synthetic conjugated estrogens bind to estrogen receptors (ERα and ERβ) in target tissues, activating genomic and non-genomic signaling pathways that regulate gene transcription and cellular functions.
0.5 to 2 mg orally once daily; or 25 mg intramuscularly once daily for 5 days; for prostate cancer: 1 to 3 mg orally once daily.
0.3 mg orally once daily
None Documented
None Documented
Terminal elimination half-life is approximately 24-48 hours, with a prolonged phase due to enterohepatic recirculation; requires dosing adjustment in hepatic impairment.
Clinical Note
moderateDiethylstilbestrol + Digoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digoxin."
Clinical Note
moderateDiethylstilbestrol + Digitoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digitoxin."
Clinical Note
moderateDiethylstilbestrol + Deslanoside
"Diethylstilbestrol may decrease the cardiotoxic activities of Deslanoside."
Clinical Note
moderateDiethylstilbestrol + Acetyldigitoxin
Terminal elimination half-life is 13-27 hours for estrone conjugates, allowing once-daily dosing.
Renal excretion of glucuronide and sulfate conjugates accounts for approximately 60-80% of an administered dose; biliary/fecal excretion accounts for 15-30%; less than 5% is excreted unchanged in urine.
Renal excretion of conjugated metabolites accounts for approximately 50-80% of elimination. Fecal/biliary excretion is minor (<10%).
Category C
Category D/X
Estrogen
Estrogen
"Diethylstilbestrol may decrease the cardiotoxic activities of Acetyldigitoxin."